Clinical Trial Update: Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study [Phase 4]

View source ↗

Summary

A Phase 4 feasibility trial evaluating new supraglottic airway devices in severely obese patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: University of Louisville | Conditions: Obesity | Phase 4 | Status: WITHDRAWN